Cannara Biotech (OTCMKTS:CNBTF – Get Free Report)’s stock price shot up 0.8% on Monday. The company traded as high as $1.55 and last traded at $1.52. 63,425 shares traded hands during trading, an increase of 91% from the average daily volume of 33,127 shares. The stock had previously closed at $1.5080.
Cannara Biotech Stock Up 0.8%
The stock’s fifty day simple moving average is $1.47 and its two-hundred day simple moving average is $1.35.
Cannara Biotech Inc. is a Canadian cannabis company focused on the cultivation, processing, and sale of indoor-grown cannabis and cannabis products. The company operates as a vertically integrated producer, managing activities ranging from cultivation and manufacturing to brand development and distribution. Cannara’s product portfolio includes dried cannabis flower, pre-rolls, cannabis concentrates, hash, vaporizers, and other consumer products. Its brands include Tribal, Nugz, and Orchid CBD, which are marketed through Canada’s regulated adult-use cannabis market and, where available, provincial distribution channels.
Recommended Stories
- Five stocks we like better than Cannara Biotech
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Cannara Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannara Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
